Format

Send to

Choose Destination
See comment in PubMed Commons below
Theranostics. 2012;2(12):1117-26. doi: 10.7150/thno.4381. Epub 2012 Dec 10.

Lipid- and polymer-based nanostructures for cancer theranostics.

Author information

1
Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.

Abstract

The relatively new field of nanotheranostics combines the advantages of in vivo diagnosis with the ability to administer treatment through a single nano-sized carrier, offering new opportunities for cancer diagnosis and therapy. Nanotheranostics has facilitated the development of nanomedicine through direct visualization of drug blood circulation and biodistribution. From a clinical perspective, nanotheranostics allows therapies to be administered and monitored in real time, thus decreasing the potential of under- or over-dosing and allowing for more personalized treatment regimens. Herein, we review recent development of nanotheranostics using lipid- and polymer-based formulations, with a particular focus on their applications in cancer research. Recent advances in nanotechnology aimed to combine therapeutic molecules with imaging agents for magnetic resonance imaging, radionuclide imaging, or fluorescence imaging are discussed.

KEYWORDS:

fluorescence imaging; liposomes; magnetic resonance imaging; nanotheranostics; polymeric nanoparticles; radionuclide imaging

PMID:
23382770
PMCID:
PMC3563151
DOI:
10.7150/thno.4381
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ivyspring International Publisher Icon for PubMed Central
    Loading ...
    Support Center